IPLab:Lab 2:Hyperplasia: Difference between revisions
No edit summary |
No edit summary |
||
| Line 26: | Line 26: | ||
* <spoiler text="What is the age-specific incidence of nodular hyperplasia in males?">The incidence of nodular hyperplasia is: | * <spoiler text="What is the age-specific incidence of nodular hyperplasia in males?">The incidence of nodular hyperplasia is: | ||
20% in men 40 years of age | * 20% in men 40 years of age | ||
30% in men 50 years of age | * 30% in men 50 years of age | ||
70% in men 60 years of age | * 70% in men 60 years of age | ||
90% in men 70 years of age</spoiler> | * 90% in men 70 years of age</spoiler> | ||
* <spoiler text="Does nodular hyperplasia predispose to adenocarcinoma?">No.</spoiler> | * <spoiler text="Does nodular hyperplasia predispose to adenocarcinoma?">No.</spoiler> | ||
* <spoiler text="What other conditions can be associated with or result from nodular hyperplasia of the prostate?">Urinary retention, cystitis, bladder distention, hypertrophy, trabeculation, diverticulum formation, renal infections, and hydronephrosis.</spoiler> | * <spoiler text="What other conditions can be associated with or result from nodular hyperplasia of the prostate?">Urinary retention, cystitis, bladder distention, hypertrophy, trabeculation, diverticulum formation, renal infections, and hydronephrosis.</spoiler> | ||